AstraZeneca Pharma India Limited: Detailed financials
Line items extracted directly from the company's exchange-filed XBRL. Click + to expand subtotals. Click any row to chart it. Monetary values are in ₹ crore.
Company financials
| Particulars | Dec-24 | Mar-25 | Jun-25 | Sep-25 | Dec-25 | Mar-26 | Jun-26 | Sep-26 |
|---|---|---|---|---|---|---|---|---|
| 440 | 480 | 526 | 559 | 612 | 579 | 683 | 729 | |
| 8 | 16 | 11 | 6 | 5 | 6 | 9 | 15 | |
| 373 | 412 | 462 | 487 | 572 | 525 | 641 | 641 | |
| 70 | 94 | 9 | — | — | — | — | — | |
| 229 | 288 | 418 | 432 | 697 | 312 | 305 | 624 | |
| −52 | −123 | −132 | −108 | −331 | 82 | 143 | −150 | |
| 62 | 66 | 64 | 60 | 94 | 46 | 79 | 68 | |
| 0.33 | 0.68 | 0.72 | 0.67 | 1 | 2 | 2 | 2 | |
| 9 | 18 | 17 | 3 | 4 | 6 | 5 | 5 | |
| 54 | 68 | 85 | 99 | 107 | 78 | 107 | 92 | |
| 51 | 97 | 92 | 76 | 51 | 66 | 58 | 96 | |
| 42 | 79 | 75 | 73 | 48 | 60 | 53 | 90 | |
| −34 | −6 | −0.36 | −5 | 1 | −1 | −0.24 | −15 | |
| 42 | 78 | 75 | 73 | 47 | 58 | 51 | 88 | |
| 11 | 20 | 19 | 19 | 14 | 13 | 13 | 26 | |
| 31 | 58 | 56 | 54 | 33 | 45 | 38 | 62 | |
| Financial ratios | ||||||||
| 11.68% | 20.15% | 17.48% | 13.60% | 8.41% | 11.37% | 8.48% | 13.13% | |
| 7.01% | 12.12% | 10.61% | 9.70% | 5.33% | 7.76% | 5.56% | 8.55% | |
| 12.34 | 23.30 | 22.33 | 21.69 | 13.04 | 17.95 | 15.17 | 24.93 | |
Revenue
₹ crore
Select any table row to compare its reported history.
Source: official NSE or BSE financial-result filings & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Derived margins, subtotals, leverage and cash-flow measures use only the displayed filed line items.